Solicitation of Nominations for Appointment to the Advisory Council for the Elimination of Tuberculosis (ACET), 42919-42920 [2019-17691]
Download as PDF
<![CDATA[
jspears on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 84, No. 160 / Monday, August 19, 2019 / Notices
workers who responded to the
September 11, 2001, terrorist attacks in
New York City, at the Pentagon, and in
Shanksville, Pennsylvania (responders),
and to eligible persons who were
present in the dust or dust cloud on
September 11, 2001 or who worked,
resided, or attended school, childcare,
or adult daycare in the New York City
disaster area (survivors). Certain specific
activities of the WTC Program
Administrator are reserved to the
Secretary, HHS, to delegate at his
discretion; other WTC Program
Administrator duties not explicitly
reserved to the Secretary, HHS, are
assigned to the Director, NIOSH. The
administration of the WTCHP STAC is
left to the Director of NIOSH in his role
as WTC Program Administrator. CDC
and NIOSH provide funding, staffing,
and administrative support services for
the WTCHP STAC. The charter was
reissued on May 12, 2019, and will
expire on May 12, 2021.
Policy on Redaction of Committee
Meeting Transcripts (Public Comment):
Transcripts will be prepared and posted
to https://www.regulations.gov within 60
days after the meeting. If a person
making a comment gives his or her
name, no attempt will be made to redact
that name. NIOSH will take reasonable
steps to ensure that individuals making
public comments are aware of the fact
that their comments (including their
name, if provided) will appear in a
transcript of the meeting posted on a
public website. Such reasonable steps
include a statement read at the start of
the meeting stating that transcripts will
be posted and names of speakers will
not be redacted. If, in making a
statement, individuals reveal personal
information (e.g., medical information)
about themselves, that information will
not usually be redacted. The CDC
Freedom of Information Act coordinator
will, however, review such revelations
in accordance with the Freedom of
Information Act and, if deemed
appropriate, will redact such
information. Disclosures of information
concerning third party medical
information will be redacted.
Matters To Be Considered: The agenda
will include discussions on research
integration activities that the WTC
Health Program is undertaking,
including research evaluation and
strategic planning; an update on the
policies and procedures in effect within
the WTC Health Program that are used
to determine whether sufficient
evidence is available to support adding
a non-cancer condition to the List of
WTC-Related Health Conditions; and an
update on the development of the
Inventory of 9/11 Agents that the
VerDate Sep<11>2014
16:29 Aug 16, 2019
Jkt 247001
Program will use for administrative
purposes. Agenda items are subject to
change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–17690 Filed 8–16–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory Council
for the Elimination of Tuberculosis
(ACET)
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
ACET. The ACET consists of 10 experts
in fields associated with public health,
epidemiology, immunology, infectious
disease, pulmonary disease, pediatrics,
tuberculosis, microbiology, or
preventive health care delivery. They
are selected by the Secretary of the U.S.
Department of Health and Human
Services (HHS). ACET provides advice
and recommendations regarding
eliminating tuberculosis (TB) to the
Secretary, HHS; the Assistant Secretary
for Health, HHS; and the CDC Director.
ACET (a) makes recommendations
regarding TB prevention and control
policies, strategies, objectives, and
priorities; (b) addresses development
and application of new technologies; (c)
provides guidance and review of CDC’s
TB prevention research portfolio and
program priorities; and (d) reviews the
extent to which progress has been made
toward eliminating TB. Nominations are
being sought for individuals who have
expertise and qualifications necessary to
contribute to the accomplishments of
ACET’s objectives. Nominees will be
selected on the basis of their expertise
in public health, epidemiology,
immunology, infectious diseases,
pulmonary disease, pediatrics,
SUMMARY:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
42919
tuberculosis, microbiology, or
preventive health care delivery. Federal
employees are ineligible for
membership. Members may be invited
to serve for up to four year terms.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of ACET’s
objectives.
DATES: Nominations for ACET
membership must be received no later
than August 31, 2019. Packages received
after that date will not be considered for
the current membership cycle.
ADDRESSES: All nominations should be
mailed to 1600 Clifton Road NE,
Mailstop E07, Atlanta, GA 30329–4027;
or emailed (recommended) to zkr7@
cdc.gov; or faxed to 404–639–8600.
FOR FURTHER INFORMATION CONTACT:
Margie Scott-Cseh, Committee
Management Specialist, NCHHSTP,
CDC, 1600 Clifton Road NE, Mailstop
E07, Atlanta, GA 30329–4027;
telephone: 404–639–8317; email: zkr7@
cdc.gov.
SUPPLEMENTARY INFORMATION: The U.S.
Department of Health and Human
Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees (SGEs), requiring the filing
of financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for ACET membership each year, and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2020, or as
soon as the HHS selection process is
complete. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. SGE Nominees must be
U.S. citizens, and cannot be full-time
employees of the U.S. Government.
Candidates should submit the following
items:
E:\FR\FM\19AUN1.SGM
19AUN1
42920
Federal Register / Vol. 84, No. 160 / Monday, August 19, 2019 / Notices
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
and email address).
D Cover letter, including a description
of the candidate qualifications and why
the candidate would be a good fit for
ACET.
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.) [see
https://www.hhs.gov/about/agencies/
hhs-agencies-and-offices/ for
a full list]).
Nominations may be submitted by the
candidate him- or herself, or by a
person/organization recommending the
candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–17691 Filed 8–16–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2019–0068; NIOSH–324]
State-Based Occupational Health
Surveillance; Request for Information
and Meeting Notice
Centers for Disease Control and
Prevention, HHS.
ACTION: Notice of public teleconference
meeting and request for information.
AGENCY:
The National Institute for
Occupational Safety and Health
(NIOSH), within the Centers for Disease
Control and Prevention (CDC),
announces a public teleconference
meeting and an opportunity to comment
on funding mechanisms and other
considerations for state-based
occupational health surveillance.
jspears on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:29 Aug 16, 2019
Jkt 247001
Comments must be received
October 18, 2019. The public
teleconference meeting will be held on
Monday, September 16, 2019, 2 p.m. to
4 p.m. EST, or after the last public
commenter in attendance has spoken,
whichever occurs first. The public
meeting will be held as a web-based
teleconference available by remote
access.
DATES:
You may submit written
comments, identified by docket
numbers CDC–2019–0068 and NIOSH–
324, by either of the following two
methods:
• Federal eRulemaking Portal: https://
www.regulations.gov Follow the
instructions for submitting comments.
• Mail: National Institute for
Occupational Safety and Health, NIOSH
Docket Office, 1090 Tusculum Avenue,
MS C–34, Cincinnati, Ohio 45226–1998.
Instructions: All information received
in response to this notice must include
the agency name and docket number
[CDC–2019–0068; NIOSH–324]. All
relevant comments received will be
posted without change to https://
www.regulations.gov, including any
personal information provided.
FOR FURTHER INFORMATION CONTACT:
Kerry Souza, 395 E St SW, Washington,
DC 20004; phone: 202–245–0639 (not a
toll free number); email: ksouza@
cdc.gov.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
Request for Information
State health agencies have a critical
role in the identification and prevention
of occupational illnesses and injuries.
NIOSH has supported state agencies
(primarily departments of public health
and, in some cases, departments of
labor) since the 1970s, through a
combination of funding and technical
assistance.1 Since that time, NIOSH has
supported states to build capacity in
occupational safety and health, ranging
from the development of case-based
surveillance to creating focused public
health interventions addressing the
occupational health needs of higher risk
populations. The work of these state
programs exemplifies the concept of
‘‘information for action’’ by ensuring
that collection, analysis, interpretation,
and dissemination of occupational
health data are linked to prevention and
control activities. Numerous examples
of these successes can be found in the
published literature, in state reports and
1 Eligible applicants include state and other
government entities such as local, county, or tribal
health departments, henceforth referred to as
‘states.’
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
on state websites, and NIOSH website
topic pages.
In 2019, NIOSH funded 26 state
occupational health surveillance
programs of varying sizes and
capacities. The portfolio of state based
activities includes 49 projects
addressing work related morbidity and
mortality, exposure reduction, or special
populations of interest.2 These states are
funded through a research cooperative
agreement mechanism. The most recent
(2014) announcement can be found at
the following web address: https://
grants.nih.gov/grants/guide/pa-files/
PAR-14-275.html.
For its state-based surveillance and
intervention cooperative agreements,
NIOSH is considering switching from a
research cooperative agreement
approach to a non-research cooperative
agreement approach. CDC generally
defines public health research as an
activity that develops or contributes to
generalizable knowledge to improve
public health practice; a non-research
activity is one that is designed to
identify and control a health problem or
improve a public health program or
service.3 A non-research mechanism
could be a public health practice
cooperative agreement or another
cooperative agreement type, and may or
may not be a better fit for the scope of
activities ordinarily conducted by
occupational health programs in a
public health context.
Under the research mechanism
currently used, submissions for funding
are evaluated on the following criteria:
Significance, investigators, innovation,
approach, and environment. Under a
non-research approach, proposals
would likely be evaluated based upon
how well the proposal identifies
important occupational health burdens
in the state; approach for tracking these
concerns; relevance and potential
impact of the public health actions
proposed; and organizational capacity of
the applicant to achieve the proposal.
This exploration of funding
mechanism type presents an
opportunity for NIOSH to receive
stakeholder input and identify the best
type from a programmatic, logistic, and
administrative point of view. Exploring
this and other approaches is
recommended by the National
Academies of Science, Engineering and
Medicine in its report ‘‘A Smarter
National Surveillance System for
2 See https://www.cdc.gov/niosh/oep/
statesurv.html.
3 CDC [2010], Distinguishing Public Health
Research and Public Health Nonresearch Policy,
https://www.cdc.gov/od/science/integrity/docs/cdcpolicy-distinguishing-public-health-researchnonresearch.pdf.
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 84, Number 160 (Monday, August 19, 2019)]
[Notices]
[Pages 42919-42920]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-17691]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Advisory
Council for the Elimination of Tuberculosis (ACET)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the ACET. The ACET consists of 10
experts in fields associated with public health, epidemiology,
immunology, infectious disease, pulmonary disease, pediatrics,
tuberculosis, microbiology, or preventive health care delivery. They
are selected by the Secretary of the U.S. Department of Health and
Human Services (HHS). ACET provides advice and recommendations
regarding eliminating tuberculosis (TB) to the Secretary, HHS; the
Assistant Secretary for Health, HHS; and the CDC Director. ACET (a)
makes recommendations regarding TB prevention and control policies,
strategies, objectives, and priorities; (b) addresses development and
application of new technologies; (c) provides guidance and review of
CDC's TB prevention research portfolio and program priorities; and (d)
reviews the extent to which progress has been made toward eliminating
TB. Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishments of ACET's
objectives. Nominees will be selected on the basis of their expertise
in public health, epidemiology, immunology, infectious diseases,
pulmonary disease, pediatrics, tuberculosis, microbiology, or
preventive health care delivery. Federal employees are ineligible for
membership. Members may be invited to serve for up to four year terms.
Selection of members is based on candidates' qualifications to
contribute to the accomplishment of ACET's objectives.
DATES: Nominations for ACET membership must be received no later than
August 31, 2019. Packages received after that date will not be
considered for the current membership cycle.
ADDRESSES: All nominations should be mailed to 1600 Clifton Road NE,
Mailstop E07, Atlanta, GA 30329-4027; or emailed (recommended) to
[email protected]; or faxed to 404-639-8600.
FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee
Management Specialist, NCHHSTP, CDC, 1600 Clifton Road NE, Mailstop
E07, Atlanta, GA 30329-4027; telephone: 404-639-8317; email:
[email protected].
SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human
Services policy stipulates that committee membership be balanced in
terms of points of view represented, and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens, and cannot be full-time employees of
the U.S. Government. Current participation on federal workgroups or
prior experience serving on a federal advisory committee does not
disqualify a candidate; however, HHS policy is to avoid excessive
individual service on advisory committees and multiple committee
memberships. Committee members are Special Government Employees (SGEs),
requiring the filing of financial disclosure reports at the beginning
and annually during their terms. CDC reviews potential candidates for
ACET membership each year, and provides a slate of nominees for
consideration to the Secretary of HHS for final selection. HHS notifies
selected candidates of their appointment near the start of the term in
July 2020, or as soon as the HHS selection process is complete. Note
that the need for different expertise varies from year to year and a
candidate who is not selected in one year may be reconsidered in a
subsequent year. SGE Nominees must be U.S. citizens, and cannot be
full-time employees of the U.S. Government. Candidates should submit
the following items:
[[Page 42920]]
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, and email address).
[ssquf] Cover letter, including a description of the candidate
qualifications and why the candidate would be a good fit for ACET.
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.) [see https://www.hhs.gov/about/agencies/hhs-agencies-and-offices/ for a
full list]).
Nominations may be submitted by the candidate him- or herself, or
by a person/organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-17691 Filed 8-16-19; 8:45 am]
BILLING CODE 4163-18-P
